Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam G McLean

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2017
Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation - a retrospective studyMichelle Willicombe, Dawn Goodall, Adam G McLean, et al.
Transplantation Direct|August 11, 2017
High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant PatientsDawn L Goodall, Michelle Willicombe, Adam G McLean, et al.
World Journal of Transplantation|March 11, 2017
Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocolMichelle Willicombe, Anna Rizzello, Dawn Goodall, et al.
Clinical Transplantation|October 14, 2014
Incidence, risk factors, and outcomes of stroke post-transplantation in patients receiving a steroid sparing immunosuppression protocolMichelle Willicombe, Nicola Kumar, Dawn Goodall, et al.
Kidney International|June 16, 2011
Paraprotein 'zippers'Vasiliki Bravou, Adam G McLean, Marina Loucaidou, et al.
Transplantation|January 17, 2014
Acute cellular rejection: impact of donor-specific antibodies and C4dMichelle Willicombe, Candice Roufosse, Paul Brookes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 28, 2004
Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapyNeill Duncan, Ajay Dhaygude, Jane Owen, et al.
Atherosclerosis|February 24, 2009
Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapyMichael S Yee, Darrell V Pavitt, William Richmond, et al.
Transplantation|October 1, 2011
Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic?Christopher Lawrence, Jack W Galliford, Michelle K Willicombe, et al.
The Review of Scientific Instruments|December 12, 2023
Demonstration of a two-dimensional divertor Thomson scattering system on DIII-DPaul J Schroeder, Fenton Glass, Thomas O'Gorman, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2017
Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation - a retrospective studyMichelle Willicombe, Dawn Goodall, Adam G McLean, et al.
Transplantation Direct|August 11, 2017
High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant PatientsDawn L Goodall, Michelle Willicombe, Adam G McLean, et al.
World Journal of Transplantation|March 11, 2017
Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocolMichelle Willicombe, Anna Rizzello, Dawn Goodall, et al.
Clinical Transplantation|October 14, 2014
Incidence, risk factors, and outcomes of stroke post-transplantation in patients receiving a steroid sparing immunosuppression protocolMichelle Willicombe, Nicola Kumar, Dawn Goodall, et al.
Kidney International|June 16, 2011
Paraprotein 'zippers'Vasiliki Bravou, Adam G McLean, Marina Loucaidou, et al.
Transplantation|January 17, 2014
Acute cellular rejection: impact of donor-specific antibodies and C4dMichelle Willicombe, Candice Roufosse, Paul Brookes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 28, 2004
Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapyNeill Duncan, Ajay Dhaygude, Jane Owen, et al.
Atherosclerosis|February 24, 2009
Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapyMichael S Yee, Darrell V Pavitt, William Richmond, et al.
Transplantation|October 1, 2011
Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic?Christopher Lawrence, Jack W Galliford, Michelle K Willicombe, et al.
The Review of Scientific Instruments|December 12, 2023
Demonstration of a two-dimensional divertor Thomson scattering system on DIII-DPaul J Schroeder, Fenton Glass, Thomas O'Gorman, et al.
Pageof 3